FeesSafety
Pluang+

[212Pb]VMT-α-NET shows strong tumor response and safety in Phase 1/2a trial for advanced neuroendocrine tumors.

Company Fundamentals
23 Oct 2026
GlobeNewsWire
View Source
Bullish
[212Pb]VMT-α-NET shows strong tumor response and safety in Phase 1/2a trial for advanced neuroendocrine tumors.

Perspective Therapeutics announced promising interim results from its Phase 1/2a trial of [212Pb]VMT-α-NET, a radiopharmaceutical targeting SSTR2-positive neuroendocrine tumors (NETs). The trial showed durable disease control with a progression-free survival rate of 72% at 18 months and objective response rates of 33% and 50% in two higher dose cohorts. The treatment was well tolerated with no dose-limiting toxicities or serious adverse events reported. The company plans to initiate Phase 3 trials in 2027 following regulatory discussions, aiming to offer a new treatment option for patients with advanced NETs.

Perspective Therapeutics' Phase 1/2a trial of [212Pb]VMT-α-NET shows promising results in advanced neuroendocrine tumors. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 23, 2026 21:32 WIB: out of 150 priced US health stocks, 19 rose and 130 fell today. Notable movers include NUVB at USD 4.45 with a -5.32% change and a typical hold time of 7 days, SANA at USD 2.25 with a -5.06% change and Pluang order activity of 46% Sell / 54% Buy, and HIMS at USD 27.73 with a -4.81% change and 85% Sell / 15% Buy order activity.

More News

Penny stocks gain attention as oil prices top $100, spotlighting innovative firms like Kraig Biocraft and Lucid Diagnostics.

Penny stocks gain attention as oil prices top $100, spotlighting innovative firms like Kraig Biocraft and Lucid Diagnostics.

With U.S. crude oil prices above $100 a barrel, investors are shifting focus to smaller companies with promising technologies and upcoming catalysts. Kraig Biocraft Laboratories shipped its first commercial spider silk yarn order, moving toward scala...

Market News
Bullish
26 minutes ago
FS Bancorp appoints Matthew D. Mullet as new director to strengthen leadership.

FS Bancorp appoints Matthew D. Mullet as new director to strengthen leadership.

FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...

Company Fundamentals
Bullish
1 hour ago
Global protein ingredients market to hit $65B by 2032, led by plant proteins and Asia-Pacific growth

Global protein ingredients market to hit $65B by 2032, led by plant proteins and Asia-Pacific growth

The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...

Market News
Bullish
1 hour ago
AX1 launches Console 2.0, enabling AI agents to work onchain with real USDC payments and weekly prizes.

AX1 launches Console 2.0, enabling AI agents to work onchain with real USDC payments and weekly prizes.

AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...

Others
Bullish
2 hours ago
Generator cooling systems market to reach $5.03B by 2031, growing 6% annually driven by data center and industrial demand.

Generator cooling systems market to reach $5.03B by 2031, growing 6% annually driven by data center and industrial demand.

The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App